AstraZeneca Says it Will Start Profiting From its Vaccinenews2021-11-13T05:15:23+00:00November 13th, 2021|The New York Times|
Democrats Choosing Less Risky Path on Drug Pricesnews2021-11-06T07:00:07+00:00November 6th, 2021|The New York Times|
Democrats Reach Deal to Control Drug Prices in Billnews2021-11-02T23:14:56+00:00November 2nd, 2021|The New York Times|
Manchin Raises Doubts on Safety Net Bill, Complicating Path to Quick Votenews2021-11-01T23:14:05+00:00November 1st, 2021|The New York Times|
This May Be Democrats’ Best Chance to Lower Drug Pricesnews2021-10-27T15:01:32+00:00October 27th, 2021|The New York Times|
Democrats’ Campaign to Control Drug Prices Nears Collapsenews2021-10-21T21:49:36+00:00October 21st, 2021|The New York Times|
‘Pharma Bro’ Review: Behind the Smirknews2021-10-05T11:00:05+00:00October 5th, 2021|The New York Times|
Drug Plan Fails, Signaling Thorny Path for Democrats’ $3.5 Trillion Billnews2021-09-16T00:32:25+00:00September 16th, 2021|The New York Times|
Democrats’ Stumble on Drug Prices Shows Power of Industrynews2021-09-15T22:28:33+00:00September 15th, 2021|The New York Times|
Biden Administration Goes Bigger on Cutting Drug Pricesnews2021-09-09T18:08:05+00:00September 9th, 2021|The New York Times|
